» Articles » PMID: 30564069

LncRNA Involvement in Hepatocellular Carcinoma Metastasis and Prognosis

Overview
Journal EXCLI J
Specialty Biology
Date 2018 Dec 20
PMID 30564069
Citations 88
Authors
Affiliations
Soon will be listed here.
Abstract

Eukaryotic lncRNAs are RNA molecules defined to be greater than 200 bp in length that are not translated to a protein and operate through several mechanisms, including participating in chromatin remodeling and methylation, influencing the integrity and stability of proteins and complexes, or acting as a sponge for miRNA inhibition. A number of recent studies have concentrated on the relationship between long non-coding RNAs (lncRNAs) and cancer. Hepatocellular carcinoma (HCC) is the most prevalent histological type of liver tumors, accounting for about 80 % of the cases worldwide. Lack of proper molecular markers for diagnosis of HCC and treatment evaluation is a significant problem. Dysregulated expression of HCC-related lncRNAs such as MEG-3, MALAT1, HULC, HOTAIR, and H19 have been identified and closely related with tumorigenesis, metastasis, prognosis and diagnosis. In this review, we summarized recent highlighted functions and molecular mechanisms of the most extensively studied lncRNAs in the pathophysiology of hepatocellular carcinoma and their potential for serving as probable therapeutic targets.

Citing Articles

Regulatory role of lnc-MAP3K13-3:1 on miR-6894-3p and SHROOM2 in modulating cellular dynamics in hepatocellular carcinoma.

Chen K, Zhu M, Hu Q, Huang H, Chen K, Shuai X BMC Cancer. 2025; 25(1):83.

PMID: 39810131 PMC: 11731390. DOI: 10.1186/s12885-024-13263-w.


Comparative transcriptome of normal and cancer-associated fibroblasts.

Abikar A, Mustafa M, Athalye R, Nadig N, Tamboli N, Babu V BMC Cancer. 2024; 24(1):1231.

PMID: 39369238 PMC: 11456241. DOI: 10.1186/s12885-024-13006-x.


Overexpression of Long Non-coding RNAs and Predict Poor Prognosis in Patients with Gastric Adenocarcinoma.

Bagheri M, Aghaabdollahian S, Rezaei M, Gholian Kholerdi A, Raei M, Keyvanloo Shahrestanaki M Adv Biomed Res. 2024; 13:34.

PMID: 39234433 PMC: 11373733. DOI: 10.4103/abr.abr_308_23.


LncRNA ZFAS1 regulates ATIC transcription and promotes the proliferation and migration of hepatocellular carcinoma through the PI3K/AKT signaling pathway.

Luo B, Zhuang L, Huang J, Shi L, Zhang L, Zhu M J Cancer Res Clin Oncol. 2024; 150(7):351.

PMID: 39001904 PMC: 11246283. DOI: 10.1007/s00432-024-05877-1.


Research Progress of Long Non-Coding RNA in Tumor Drug Resistance: A New Paradigm.

Zhang J, Wu L, Wang C, Xie X, Han Y Drug Des Devel Ther. 2024; 18:1385-1398.

PMID: 38689609 PMC: 11060174. DOI: 10.2147/DDDT.S448707.


References
1.
Wang F, Ying H, He B, Pan Y, Deng Q, Sun H . Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway. Oncotarget. 2015; 6(10):7899-917. PMC: 4480724. DOI: 10.18632/oncotarget.3219. View

2.
Huang J, Guo Y, Zhao C, Yuan S, Wang Y, Tang G . Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin. Hepatology. 2012; 57(5):1882-92. DOI: 10.1002/hep.26195. View

3.
Brockdorff N, Ashworth A, Kay G, McCabe V, Norris D, Cooper P . The product of the mouse Xist gene is a 15 kb inactive X-specific transcript containing no conserved ORF and located in the nucleus. Cell. 1992; 71(3):515-26. DOI: 10.1016/0092-8674(92)90519-i. View

4.
Zheng Z, Pang C, Yang Y, Duan Q, Zhang J, Liu W . Serum long noncoding RNA urothelial carcinoma-associated 1: A novel biomarker for diagnosis and prognosis of hepatocellular carcinoma. J Int Med Res. 2017; 46(1):348-356. PMC: 6011314. DOI: 10.1177/0300060517726441. View

5.
Zhang Y, Lu Y, Yuan B, Castranova V, Shi X, Stauffer J . The Human mineral dust-induced gene, mdig, is a cell growth regulating gene associated with lung cancer. Oncogene. 2005; 24(31):4873-82. DOI: 10.1038/sj.onc.1208668. View